Skip to main content

Advertisement

Fig. 5 | Cardiovascular Diabetology

Fig. 5

From: MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin

Fig. 5

MiR-21 attenuates diabetic condition-induced cardiomyocyte hypertrophy in vitro. a Relative expression of miR-21 in treated H9c2 cells. b Representative images and relative cell area determined by quantitation analysis of cardiomyocyte by Phalloidin staining in treated H9c2 cells. ce Relative expression levels of ANP, BNP, and β-MHC/α-MHC in treated H9c2 cells. f ROS generation in treated H9c2 cells. g Relative NO levels in treated H9c2 cells. h Protein levels of p-Akt(Ser473) and p-eNOS(Ser 1177) in treated H9c2 cells

Back to article page